Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome
byAmerican College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi)
Updated on: February 18,2024
21
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome
byAmerican College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi)
Updated on:February 18,2024
21